Imagion Biosystems raises AU$3.75M after FDA clears Phase 2 trial

June 25, 2026 11:52 AM

Imagion Biosystems, Ltd. (ASX: IBX) has secured AU$3.75M (US$2.59M) in new capital following FDA clearance of its investigational new drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found